Document is current
Any future updates will be listed below
-
Authors
Wallace, Zachary S.
Park, Jenny Y.
Serra, Elizabeth
Gagnon-Sanschagrin, Patrick
Guérin, Annie
Patterson, Kristina
Patel, Haridarshan
Singh, Vikesh K.
-
Funding
Funding for this research was provided by:
Amgen Inc
- License Information
-
More Information
Article History
Received: 13 January 2025
Accepted: 25 March 2025
First Online: 8 April 2025
Declarations
:
: Zachary S. Wallace has received consulting fees from Amgen Inc and is now an employee of Amgen, but this study was conducted prior to his employment at Amgen. Jenny Y. Park, Kristina Patterson, and Haridarshan Patel are employees and stockholders of Amgen Inc. Elizabeth Serra, Patrick Gagnon-Sanschagrin, and Annie Guérin are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Amgen Inc, which funded the development and conduct of this study and manuscript. Vikesh K. Singh has provided paid consulting services to Amgen, Panafina, and Ariel Precision Medicine.
: The study was considered exempt research under 45 CFR § 46.104(d)(4) as it involved only the secondary use of data that were de-identified in compliance with the Health Insurance Portability and Accountability Act (HIPAA), specifically, 45 CFR § 164.514.
